Tirzepatide

30mg

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its role in glycemic control and metabolic regulation. Research has demonstrated its unique mechanism of action through simultaneous activation of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways. The 30mg formulation is the highest quantity available for advanced research protocols.